Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 2001
Medical Areas: Pulmonary/Respiratory Diseases | Family Medicine | Infections and Infectious Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Tavist (clemastine fumarate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Novartis
Approval Status: Approved March 2001
Treatment Area: Cold and Allergy

General Information

Tavist Allergy/Sinus/Headache, an over-the-counter medication, has been approved for the temporary relief of symptoms associated with hay fever, allergic rhinitis, and the common cold. These may include, sinus congestion and pressure, runny nose and sneezing, itchy throat, and itchy, watery eyes. Tavist Allergy/Sinus/Headache is the only over-the-counter medication to combine the antihistamine clemastine fumarate with a nasal decongestant and pain reliever.

Side Effects

General adverse events associated with the use of an analgesic, antihistamine, decongestant combination medication may include (but are not limited to) the following:


  • Drowsiness
  • Nausea
  • Stomach pain

Mechanism of Action

Tavist Allergy/Sinus/Headache contains the analgesic acetaminophen, the antihistamine clemastine fumarate, and the decongestant pseudoephedrine hydrochloride.

Additional Information

For additional information on Tavist Allergy/Sinus/Headache, please visit Novartis Consumer Products.